Risk-stratified Testing for Safe Removal of Penicillin Allergy Labels

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions
Penicillin AllergyHypersensitivity, ImmediateHypersensitivity, DelayedHypersensitivity Response
Interventions
OTHER

Direct Oral challenge

Patients will receive a 1-step or 2-step challenge with the suspected penicillin and will be monitored for any allergic reaction within the first four hours. Patients will be instructed to contact the hospital after the drug provocation test to inquire delayed allergic reactions.

OTHER

standard of care

The patient will receive skin prick test and patch test (if a delayed allergy is suspected). Allergen-specific IgE will be measured. If all negative, drug provocation tets will be performed identical to the experimental group.

Trial Locations (2)

69120

RECRUITING

University Hospital Heidelberg, Dermatology, Heidelberg

RECRUITING

University Hospital Heidelberg, Division of Infectious Diseases and Tropical Medicine, Heidelberg

All Listed Sponsors
lead

Deniz Göcebe

OTHER